GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Pharbaco Central Pharmaceutical JSC No 1 (HSTC:PBC) » Definitions » Short Percentage of Float

Pharbaco Central Pharmaceutical JSC No 1 (HSTC:PBC) Short Percentage of Float


View and export this data going back to 2019. Start your Free Trial

What is Pharbaco Central Pharmaceutical JSC No 1 Short Percentage of Float?

Short Percentage of Float is the percentage of shares shorted compared to the float.

Due to the license agreement change with our data vendor, Short Interest related data is no longer available on GuruFocus website.


Competitive Comparison of Pharbaco Central Pharmaceutical JSC No 1's Short Percentage of Float

For the Drug Manufacturers - Specialty & Generic subindustry, Pharbaco Central Pharmaceutical JSC No 1's Short Percentage of Float, along with its competitors' market caps and Short Percentage of Float data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Pharbaco Central Pharmaceutical JSC No 1's Short Percentage of Float Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Pharbaco Central Pharmaceutical JSC No 1's Short Percentage of Float distribution charts can be found below:

* The bar in red indicates where Pharbaco Central Pharmaceutical JSC No 1's Short Percentage of Float falls into.


;
;

Pharbaco Central Pharmaceutical JSC No 1 Business Description

Comparable Companies
Traded in Other Exchanges
N/A
Address
160 Ton Duc Thang, Hang Bot ward, Dong Da District, Hanoi, VNM
Pharbaco Central Pharmaceutical JSC No 1 is a pharmaceutical company. Some of its products include Cefadroxil 250mg, Elnizol infusion drug, and Fabafixim 50.

Pharbaco Central Pharmaceutical JSC No 1 Headlines

No Headlines